Background: Some studies have advocated marrow penetration in guided bone augmentation (GBA), whereas others have shown that bone can be generated without marrow penetration. This study examined the effect of marrow penetration and the optimal rate of penetration.

Methods: In 10 rabbits, the calvarium was exposed, and circular grooves were prepared bilaterally. Within the circular groove, the external cortical surface of the skull was perforated mechanically using a number 4 round bur (experimental site), whereas the bone surface on the other groove (control site) was left intact. The rate of penetration was standardized as 28% for the experimental site and 0% for the control site. Subsequently, two standardized titanium caps with an inner diameter of 8 mm and an inner height of 4 mm were anchored in the prepared grooves. Five rabbits each were euthanized at 1 and 3 months, and the percent area of newly generated tissue and mineralized bone in the newly generated tissue under the titanium cap was determined.

Results: Histomorphometric analysis showed significantly increased bone neogenesis in the experimental site at 3 months. The percent area of mineralized bone in the newly generated tissue was consistently higher in the experimental site at 3 months.

Conclusion: In the rabbit calvarium using a titanium cap GBA model, bone augmentation was significantly greater with marrow penetration than without penetration.

Download full-text PDF

Source
http://dx.doi.org/10.1902/jop.2007.070086DOI Listing

Publication Analysis

Top Keywords

marrow penetration
20
experimental site
16
bone augmentation
12
titanium cap
12
newly generated
12
generated tissue
12
bone
8
rabbit calvarium
8
control site
8
months percent
8

Similar Publications

Deer antler blastema progenitor cells (ABPCs) are promising for regenerative medicine due to their role in annual antler regeneration, the only case of complete organ regeneration in mammals. ABPC-derived signals show great potential for promoting regeneration in tissues with limited natural regenerative ability. Our findings demonstrate the capability of extracellular vesicles from ABPCs (EVs) to repair spinal cord injury (SCI), a condition with low regenerative capacity.

View Article and Find Full Text PDF

Discovery of Potent and Selective CDK4/6 Inhibitors for the Treatment of Chemotherapy-Induced Myelosuppression.

J Med Chem

January 2025

State Key Laboratory of Natural Medicines, Departemnt of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

Article Synopsis
  • Chemotherapy-induced myelosuppression (CIM) hinders blood cell production, making it a significant issue in cancer treatment.
  • Trilaciclib (TC) is the only FDA-approved CDK4/6 inhibitor that protects bone marrow by stopping the growth of certain cells, and its derivatives show strong potential as effective treatments for CIM.
  • Among these, one derivative displayed excellent inhibitory activity, low toxicity, great selectivity, and effective penetration into bone marrow, indicating it could improve treatment outcomes for individuals experiencing myelosuppression from chemotherapy.
View Article and Find Full Text PDF

Chronic myeloid leukemia (CML) typically progresses from a chronic phase to an accelerated phase, and eventually to a blast crisis, often involving the bone marrow and peripheral blood, if left untreated. Central nervous system (CNS) involvement is an uncommon manifestation of CML, particularly as an isolated CNS relapse. Here, we present a rare case of CML in lymphoid blast crisis with an isolated CNS relapse.

View Article and Find Full Text PDF

RANKL and its receptor RANK play a vital role in osteoclastogenesis. RANK primarily recruits TRAFs to promote osteoclastogenesis but also contains an TRAF-independent motif (IVVY), which mediates osteoclast lineage commitment in vitro. Here, we have developed knockin mice in which inactivating mutations are introduced in the IVVY motif (IVVY to IVAF).

View Article and Find Full Text PDF

A detailed evaluation of the advantages among extracellular vesicles from three cell origins for targeting delivery of celastrol and treatment of glioblastoma.

Int J Pharm

December 2024

Beijing Key Laboratory of Traditional Chinese Medicine Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China. Electronic address:

As one of the most common brain tumors, glioblastoma (GBM) lacks efficient therapeutic treatment and remains lethal. Extracellular vesicles (EVs) have emerged as a promising platform for GBM therapies. Nevertheless, the properties of EVs are significantly influenced by their cell origins.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!